当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukemia: Results of the EORTC CLG 58881 and 58951 trials
Leukemia ( IF 12.8 ) Pub Date :  , DOI: 10.1038/leu.2017.289
C Piette , S Suciu , E Clappier , Y Bertrand , S Drunat , S Girard , K Yakouben , G Plat , N Dastugue , F Mazingue , N Grardel , N van Roy , A Uyttebroeck , V Costa , O Minckes , N Sirvent , P Simon , P Lutz , A Ferster , C Pluchart , M Poirée , C Freycon , M-F Dresse , F Millot , C Chantrain , J van der Werff ten Bosch , K Norga , C Gilotay , P-S Rohrlich , Y Benoit , H Cavé

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukemia: Results of the EORTC CLG 58881 and 58951 trials

Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.289



中文翻译:

药物对ETV6-RUNX1阳性儿童B细胞前体急性淋巴细胞白血病预后的不同影响:EORTC CLG 58881和58951试验的结果

药物对ETV6-RUNX1阳性儿童B细胞前体急性淋巴细胞白血病预后的不同影响:EORTC CLG 58881和58951试验的结果

白血病,在线发布:2017年9月19日; doi:10.1038 / leu.2017.289

更新日期:2017-09-20
down
wechat
bug